Zhou W - Search Results

1

PML-mediated signaling and its role in cancer stem cells.

Zhou W, Bao S. Zhou W, et al. Oncogene. 2014 Mar 20;33(12):1475-84. doi: 10.1038/onc.2013.111. Epub 2013 Apr 8. Oncogene. 2014. PMID: 23563177 Review.

2

p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.

Xu LZ, Li SS, Zhou W, Kang ZJ, Zhang QX, Kamran M, Xu J, Liang DP, Wang CL, Hou ZJ, Wan XB, Wang HJ, Lam EW, Zhao ZW, Liu Q. Xu LZ, et al. Among authors: zhou w. Oncogene. 2017 Jan 19;36(3):304-317. doi: 10.1038/onc.2016.202. Epub 2016 Jun 27. Oncogene. 2017. PMID: 27345399 Free PMC article.

3

Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.

Jiang LQ, Feng X, Zhou W, Knyazev PG, Ullrich A, Chen Z. Jiang LQ, et al. Among authors: zhou w. Oncogene. 2006 Sep 7;25(40):5495-506. doi: 10.1038/sj.onc.1209554. Epub 2006 Apr 24. Oncogene. 2006. PMID: 16636672

4

Overexpression of Csk-binding protein contributes to renal cell carcinogenesis.

Feng X, Lu X, Man X, Zhou W, Jiang LQ, Knyazev P, Lei L, Huang Q, Ullrich A, Zhang Z, Chen Z. Feng X, et al. Among authors: zhou w. Oncogene. 2009 Sep 17;28(37):3320-31. doi: 10.1038/onc.2009.185. Epub 2009 Jul 6. Oncogene. 2009. PMID: 19581936

5

LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells.

Taliaferro-Smith L, Nagalingam A, Zhong D, Zhou W, Saxena NK, Sharma D. Taliaferro-Smith L, et al. Among authors: zhou w. Oncogene. 2009 Jul 23;28(29):2621-33. doi: 10.1038/onc.2009.129. Epub 2009 Jun 1. Oncogene. 2009. PMID: 19483724 Free PMC article.

6

p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.

Zhu J, Nozell S, Wang J, Jiang J, Zhou W, Chen X. Zhu J, et al. Among authors: zhou w. Oncogene. 2001 Jul 5;20(30):4050-7. doi: 10.1038/sj.onc.1204516. Oncogene. 2001. PMID: 11494133

7

Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer.

Chen C, Sun X, Guo P, Dong XY, Sethi P, Zhou W, Zhou Z, Petros J, Frierson HF Jr, Vessella RL, Atfi A, Dong JT. Chen C, et al. Among authors: zhou z, zhou w. Oncogene. 2007 Apr 5;26(16):2386-94. doi: 10.1038/sj.onc.1210021. Epub 2006 Oct 2. Oncogene. 2007. PMID: 17016436

8

Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.

Zhu J, Jiang J, Zhou W, Zhu K, Chen X. Zhu J, et al. Among authors: zhou w. Oncogene. 1999 Mar 25;18(12):2149-55. doi: 10.1038/sj.onc.1202533. Oncogene. 1999. PMID: 10321740

9

Immediate early response protein 2 promotes the migration and invasion of hepatocellular carcinoma cells via regulating the activity of Rho GTPases.

Xu X, Zhou W, Chen Y, Wu K, Wang H, Zhang J, Zhou Y, Zeng J, Yang J, Deng Z, Zhang Y, Shen W. Xu X, et al. Among authors: zhou y, zhou w. Neoplasma. 2020 May;67(3):614-622. doi: 10.4149/neo_2020_190818N781. Epub 2020 Feb 3. Neoplasma. 2020. PMID: 32009420

10

The potential tumor suppressor p73 differentially regulates cellular p53 target genes.

Zhu J, Jiang J, Zhou W, Chen X. Zhu J, et al. Among authors: zhou w. Cancer Res. 1998 Nov 15;58(22):5061-5. Cancer Res. 1998. PMID: 9823311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21,250 results

Search Page